Clinical Research Directory
Browse clinical research sites, groups, and studies.
Branched-chain Aminoacids in Sleep Apnea Syndromes (ARSAS)
Sponsor: University Hospital, Limoges
Summary
The initial hypothesis is that branched-chain aminoacids (BCAA) administration could be beneficial to patients suffering from sleep apnea syndrome (SAS), the aim of the present work is to verify this hypothesis. The literature data demonstrate that a BCAA complementation improves the physical performances, protects lean mass and increases VO2 max during training. We demonstrated earlier that this complementation can cure at less partly the hypoxemia of chronic obstructive pulmonary patients by a stimulation of respiratory centres.
Official title: Which Place for Branched-chain Aminoacids in the Treatment of Sleep Apnea Syndromes?
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
0
Start Date
2010-06
Completion Date
2012-06
Last Updated
2026-06-09
Healthy Volunteers
No
Conditions
Interventions
Branched-chain aminoacids
Branched-chain aminoacids will be orally administered in the form of capsules, at the rate of a capsule for physical 7 Kilograms weighty and a day. Every capsule containing 375 milligrams of branched-chain aminoacids. The treatment will last 3 weeks.
Placebo
Placebo will be orally administered in the form of capsules, at the rate of a capsule for physical 7 Kilograms weighty and a day. The treatment will last 3 weeks.